Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harvard Bioscience (HBIO) Non-Current Deferred Tax Liability (2016 - 2025)

Historic Non-Current Deferred Tax Liability for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $733000.0.

  • Harvard Bioscience's Non-Current Deferred Tax Liability rose 367.75% to $733000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $733000.0, marking a year-over-year increase of 367.75%. This contributed to the annual value of $710000.0 for FY2024, which is 850.52% down from last year.
  • Latest data reveals that Harvard Bioscience reported Non-Current Deferred Tax Liability of $733000.0 as of Q3 2025, which was up 367.75% from $734000.0 recorded in Q2 2025.
  • Harvard Bioscience's Non-Current Deferred Tax Liability's 5-year high stood at $2.4 million during Q2 2022, with a 5-year trough of $546000.0 in Q1 2023.
  • Over the past 5 years, Harvard Bioscience's median Non-Current Deferred Tax Liability value was $764000.0 (recorded in 2024), while the average stood at $1.0 million.
  • Its Non-Current Deferred Tax Liability has fluctuated over the past 5 years, first surged by 5438.93% in 2022, then plummeted by 7251.75% in 2023.
  • Over the past 5 years, Harvard Bioscience's Non-Current Deferred Tax Liability (Quarter) stood at $1.6 million in 2021, then tumbled by 62.13% to $590000.0 in 2022, then surged by 31.53% to $776000.0 in 2023, then decreased by 8.51% to $710000.0 in 2024, then grew by 3.24% to $733000.0 in 2025.
  • Its Non-Current Deferred Tax Liability was $733000.0 in Q3 2025, compared to $734000.0 in Q2 2025 and $717000.0 in Q1 2025.